Meitav Investment House’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,409
| Closed | -$336K | – | 409 |
|
|
2023
Q2 | $336K | Buy |
4,409
+1,348
| +44% | +$103K | 0.01% | 307 |
|
|
2023
Q1 | $250K | Sell |
3,061
-1,498
| -33% | -$122K | ﹤0.01% | 332 |
|
|
2022
Q4 | $389K | Hold |
4,559
| – | – | 0.01% | 305 |
|
|
2022
Q3 | $287K | Buy |
+4,559
| New | +$287K | 0.01% | 325 |
|
|
2022
Q1 | – | Sell |
-4,061
| Closed | -$297K | – | 393 |
|
|
2021
Q4 | $297K | Sell |
4,061
-4,500
| -53% | -$329K | ﹤0.01% | 345 |
|
|
2021
Q3 | $603K | Sell |
8,561
-500
| -6% | -$35.2K | 0.01% | 295 |
|
|
2021
Q2 | $619K | Buy |
9,061
+5,000
| +123% | +$342K | 0.02% | 288 |
|
|
2021
Q1 | $263 | Sell |
4,061
-2,200
| -35% | -$142 | 0.01% | 334 |
|
|
2020
Q4 | $361K | Sell |
6,261
-3,200
| -34% | -$185K | 0.01% | 319 |
|
|
2020
Q3 | $593K | Buy |
9,461
+3,000
| +46% | +$188K | 0.03% | 234 |
|
|
2020
Q2 | $491K | Sell |
6,461
-8,849
| -58% | -$672K | 0.03% | 227 |
|
|
2020
Q1 | $1.15M | Buy |
15,310
+9,960
| +186% | +$751K | 0.09% | 128 |
|
|
2019
Q4 | $348K | Sell |
5,350
-90
| -2% | -$5.85K | 0.03% | 295 |
|
|
2019
Q3 | $348K | Hold |
5,440
| – | – | 0.03% | 298 |
|
|
2019
Q2 | $364K | Sell |
5,440
-2,450
| -31% | -$164K | 0.02% | 302 |
|
|
2019
Q1 | $506K | Buy |
7,890
+293
| +4% | +$18.8K | 0.03% | 238 |
|
|
2018
Q4 | $453K | Sell |
7,597
-533
| -7% | -$31.8K | 0.03% | 211 |
|
|
2018
Q3 | $621K | Sell |
8,130
-3,479
| -30% | -$266K | 0.03% | 268 |
|
|
2018
Q2 | $998K | Sell |
11,609
-874
| -7% | -$75.1K | 0.04% | 204 |
|
|
2018
Q1 | $939K | Buy |
12,483
+2,743
| +28% | +$206K | 0.05% | 170 |
|
|
2017
Q4 | $704K | Buy |
+9,740
| New | +$704K | 0.04% | 143 |
|